title: Anti-Nogo-A antibody: a treatment option for neurogenic lower urinary tract dysfunction?
authors.affiliation: Brain Research Institute, University of Zürich, Zürich, Switzerland; Neuro-Urology, Spinal Cord Injury Center and Research, Balgrist University Hospital, University of Zürich, Zürich, Switzerland; Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.
authors.forename: Marc P
authors.initials: MP
authors.lastname: Schneider
authors.forename: Martin E
authors.initials: ME
authors.lastname: Schwab
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Kessler
mesh_terms: D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D058851:GPI-Linked Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000209:etiology / Q000628:therapy*; D009185:Myelin Proteins / Q000037:antagonists & inhibitors / Q000276:immunology*; D009416:Nerve Regeneration / Q000502:physiology*; D000070798:Nogo Proteins; D000070816:Nogo Receptor 1; D051381:Rats; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors; D013119:Spinal Cord Injuries / Q000150:complications; D001750:Urinary Bladder, Neurogenic / Q000209:etiology / Q000628:therapy*
chemical_list: D000906:Antibodies; D058851:GPI-Linked Proteins; D009185:Myelin Proteins; D000070798:Nogo Proteins; D000070816:Nogo Receptor 1; C000603199:RTN4 protein, human; C486580:RTN4R protein, human; D011956:Receptors, Cell Surface; C000603197:Rtn4 protein, rat